Online pharmacy PlatinumRx raises $6 million in round led by Stellaris Venture Partners

Share via:



Bengaluru-based online pharmacy PlatinumRx has raised $6 million in a funding round led by Stellaris Venture Partners with participation from existing investor India Quotient.

The platform helps customers find substitute brands for affordable medicines. It plans to use the fresh capital to scale operations, add new fulfilment centres and expand the product and tech teams.

“India has a very unique problem where doctors write a very specific name of the medicine brand on the prescription. So, the idea was to figure out where people can buy the same…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Online pharmacy PlatinumRx raises $6 million in round led by Stellaris Venture Partners



Bengaluru-based online pharmacy PlatinumRx has raised $6 million in a funding round led by Stellaris Venture Partners with participation from existing investor India Quotient.

The platform helps customers find substitute brands for affordable medicines. It plans to use the fresh capital to scale operations, add new fulfilment centres and expand the product and tech teams.

“India has a very unique problem where doctors write a very specific name of the medicine brand on the prescription. So, the idea was to figure out where people can buy the same…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Nvidia, joining Big Tech deal spree, to license Groq...

Nvidia has agreed to license chip technology from...

MacSync Stealer variant bypasses Apple malware protections

We’ve recently seen how ChatGPT was used to...

Urban Company In 2025, Outage At Rapido & More

Wishing you a happy Christmas from everyone at...

Popular